Cargando…
The association of medical providers’ attitudes about naloxone and people with opioid use disorder and their self-reported “low-barrier” treatment practices
Opioid-involved overdose deaths continue to climb, in part because of suboptimal access to and retention on medications for opioid use disorder (MOUD), including buprenorphine. Low barrier buprenorphine treatment aims to reduce or eliminate the threshold for getting and staying on medication by prov...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480593/ https://www.ncbi.nlm.nih.gov/pubmed/37680698 http://dx.doi.org/10.1016/j.abrep.2023.100514 |